Specific binding agents to varicella-zoster virus and uses related thereto
US11147870B2 · kind B2 · utility
0Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2019 |
| Grant date | Oct 19, 2021 |
| Priority date | — |
| Expiry date | Apr 25, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16734
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to specific binding agents to varicella-zoster virus proteins or glycoproteins. In certain embodiments the specific binding agents are antibodies and binding fragments thereof disclosed herein. In certain embodiments, this disclosure relates to methods of treating or preventing a varicella-zoster infection comprising administering an effective amount of a specific binding agent disclosed herein to a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.